Lars Schimmoller
Overview
Explore the profile of Lars Schimmoller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meissner V, Dinkel A, Kron M, Schiele S, Jahnen M, Lakes J, et al.
J Behav Med
. 2025 Mar;
PMID: 40042752
Cancer worry and risk perception are relevant psychological factors that influence preventive health behaviors. Therefore, a thorough understanding of the factors that impact their occurrence and manifestation is critical. The...
2.
Valentin B, Schimmoller L, Boschheidgen M, Ullrich T, Thiel T, Ljimani A, et al.
Sci Rep
. 2025 Jan;
15(1):3451.
PMID: 39870725
Aim of this study was to proof the concept of optimizing the contrast between prostate cancer (PC) and healthy tissue by DWI post-processing using a quadrature method. DWI post-processing was...
3.
Ullrich T, Boschheidgen M, Schweyen C, Franiel T, Valentin B, Quentin M, et al.
Rofo
. 2025 Jan;
PMID: 39775575
Evaluation of the current status, significance and availability of multiparametric prostate MRI and MRI-guided biopsy in Germany.A voluntary web-based questionnaire with 26 distinct items was emailed to members of the...
4.
Novruzov E, Niegisch G, Pauck D, Schmitt D, Kuhlmann J, Beseoglu K, et al.
BJR Case Rep
. 2024 Nov;
10(6):uaae041.
PMID: 39553424
Prostate adenocarcinoma metastasis to brain has been reported to occur only up to 0.6% of patients and these are mostly diagnosed in autopsy series. In the setting of biochemical recurrence...
5.
von Ostau N, Handke A, Wiesenfarth M, Albers P, Antoch G, Noldus J, et al.
World J Urol
. 2024 Sep;
42(1):530.
PMID: 39302458
Background: This study aimed to validate a previously published risk model (RM) which combines clinical and multiparametric MRI (mpMRI) parameters to predict extraprostatic extension (EPE) of prostate cancer (PC) prior...
6.
De Vrieze M, Hubner A, Al-Monajjed R, Albers P, Radtke J, Schimmoller L, et al.
Radiologie (Heidelb)
. 2024 Jun;
64(7):545.
PMID: 38884640
No abstract available.
7.
Wittsack H, Thiel T, Valentin B, Stabinska J, Benkert T, Schimmoller L, et al.
Magn Reson Med
. 2024 Jun;
92(5):2074-2080.
PMID: 38852176
Purpose: Development of a color scheme representation to facilitate the interpretation of tri-exponential DWI data from abdominal organs, where multi-exponential behavior is more pronounced. Methods: Multi-exponential analysis of DWI data...
8.
Krilaviciute A, Kaaks R, Seibold P, De Vrieze M, Lakes J, Radtke J, et al.
Eur Urol
. 2024 May;
86(6):493-500.
PMID: 38749854
Background: Risk-adjusted screening for prostate cancer (PCa) aims to reduce harms by less frequent retesting, especially in men at a low risk of PCa. Definitions of low risk are based...
9.
De Vrieze M, Hubner A, Al-Monajjed R, Albers P, Radtke J, Schimmoller L, et al.
Radiologie (Heidelb)
. 2024 May;
64(6):479-487.
PMID: 38743100
Background: The harm-to-benefit ratio of prostate cancer (PCa) screening remains controversial mainly due to the unfavorable test characteristics of prostate-specific antigen (PSA) as a screening test. Methods: In this nonsystematic...
10.
Thiel T, Valentin B, Ullrich T, Boschheidgen M, Schimmoller L, Benkert T, et al.
J Magn Reson Imaging
. 2024 Apr;
61(1):512-515.
PMID: 38581176
No abstract available.